Mutant prion protein acquires resistance to protease in mouse neuroblastoma cells

Journal of General Virology

Volumn 83, Issue 5, 2002, Pages 1237-1245

  Wegner, C ^a   Romer A ^a   Schmalzbauer, R ^a   Lorenz, H ^a   Windl, Otto ^a   Kretzschmar, Hans A ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ALANINE DERIVATIVE; DOXYCYCLINE; GLYCINE DERIVATIVE; GUANINE; ISOPROTEIN; MUTANT PROTEIN; PRION PROTEIN; PROTEINASE K; TETRACYCLINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE DELETION; GENETIC RESISTANCE; HYDROPHOBICITY; MOLECULAR EVOLUTION; MOUSE; MUTATIONAL ANALYSIS; NEUROBLASTOMA CELL; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN STRUCTURE; PROTEIN SYNTHESIS;

ANIMALIA; MURINAE;

EID: 0036257318     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-83-5-1237     Document Type: Article

References (54)

1. Scrapie and cellular prion proteins differ in their kinetics of synthesis and topology in cultured cells
2. Normal host prion protein necessary for scrapie-induced neurotoxicity
3. Prion protein peptides: Optimal toxicity and peptide blockade of toxicity
4. Sc-like prion protein peptide inhibits the function of cellular prion protein
5. Role of microglia and host prion protein in neurotoxicity of prion protein fragment
6. The cellular prion protein binds copper in vivo
7. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity
8. Mice devoid of PrP are resistant to scrapie
9. Sc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene
10. Prion protein biosynthesis in scrapie-infected and uninfected neuroblastoma cells
11. Secondary structure analysis of the scrapie-associated protein PrP27-30 in water by infrared spectroscopy
12. Specific inhibition of in vitro formation of protease-resistant prion protein by synthetic peptides
13. Truncated forms of the human prion protein in normal brain and in prion diseases
14. Identification of intermediate steps in the conversion of a mutant prion protein to a scrapie-like form in cultured cells
15. Structure of recombinant full-length hamster prion protein PrP(29-231): The N terminus is highly flexible
16. Neurotoxicity of a prion protein fragment
17. Predicted α-helical regions of the prion protein when synthesized as peptides form amyloid
18. Asparagine-linked glycosylation of the scrapie and cellular prion proteins
19. Processing of a cellular prion protein: Identification of N- and C-terminal cleavage sites
20. A transmembrane form of the prion protein in neurodegenerative disease
21. Transmissible and genetic prion diseases share a common pathway of neurodegeneration
22. Evidence of presynaptic location and function of the prion protein
23. A general method of in vitro preparation and specific mutagenesis of DNA fragments: Study of protein and DNA interactions
24. Sc accumulation
25. Recombinant full-length murine prion protein, mPrP(23-231): Purification and spectroscopic characterization
26. Mutant prion proteins are partially retained in the endoplasmic reticulum
27. Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues
28. Neuroblastoma: Cell culture analysis of a differentiating stem cell system
29. Sc)-specific epitope defined by a monoclonal antibody
30. Generation of monoclonal antibodies against human prion proteins in PrP0/0 mice
31. Immobilon-P transfer membrane: Applications and utility in protein biochemical analysis
32. Mutant and infectious prion proteins display common biochemical properties in cultured cells
33. Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells
34. Solution structure of Syrian hamster prion protein rPrP(90-231)
35. Signal transduction through prion protein
36. Recombinant scrapie-like prion protein of 106 amino acids is soluble
37. Purification and properties of the cellular prion protein from Syrian hamster brain
38. Conversion of α-helices into β-sheets features in the formation of the scrapie prion proteins
39. Effect of the D178N mutation and the codon 129 polymorphism on the metabolism of the prion protein
40. Abnormal properties of prion protein with insertional mutations in different cell types
41. Prion diseases and neurodegeneration
42. Prion diseases of humans and animals
43. Copper converts the cellular prion protein into a protease-resistant species that is distinct from the scrapie isoform
44. NMR structure of the mouse prion protein domain PrP(121-231)
45. NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231)
46. Epitope mapping of the Syrian hamster prion protein utilizing chimeric and mutant genes in a vaccinia virus expression system
47. Conformational transitions, dissociation, and unfolding of scrapie amyloid (prion) protein
48. Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques
49. A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells
50. Prion protein aggregation reverted by low temperature in transfected cells carrying a prion protein gene mutation
51. Most pathogenic mutations do not alter the membrane topology of the prion protein
52. Doxycycline control of prion protein transgene expression modulates prion disease in mice
53. Copper binding to the prion protein: Structural implications of four identical cooperative binding sites
54. Construction and characterization of murine neuroblastoma cell clones allowing inducible and high expression of the prion protein